| 000 | 01531 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513033649.0 | ||
| 264 | 0 | _c19950810 | |
| 008 | 199508s 0 0 eng d | ||
| 022 | _a0090-9556 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPalamanda, J R | |
| 245 | 0 | 0 |
_aDapsone acetylation by human liver arylamine N-acetyltransferases and interaction with antiopportunistic infection drugs. _h[electronic resource] |
| 260 |
_bDrug metabolism and disposition: the biological fate of chemicals _cApr 1995 |
||
| 300 |
_a473-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAcetylation |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aArylamine N-Acetyltransferase _xbiosynthesis |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 | _aCloning, Molecular |
| 650 | 0 | 4 |
_aCytosol _xdrug effects |
| 650 | 0 | 4 |
_aDapsone _xmetabolism |
| 650 | 0 | 4 |
_aEscherichia coli _xenzymology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 |
_aOpportunistic Infections _xdrug therapy |
| 650 | 0 | 4 | _aPhenotype |
| 700 | 1 | _aHickman, D | |
| 700 | 1 | _aWard, A | |
| 700 | 1 | _aSim, E | |
| 700 | 1 | _aRomkes-Sparks, M | |
| 700 | 1 | _aUnadkat, J D | |
| 773 | 0 |
_tDrug metabolism and disposition: the biological fate of chemicals _gvol. 23 _gno. 4 _gp. 473-7 |
|
| 999 |
_c7600354 _d7600354 |
||